
3 Mining Castings Maker, Pharmaceuticals Company and Adhesives and Construction Chemicals Maker Stocks With a Strong Future Roadmap: AIA Engineering, Cipla and Pidilite Industries
AIA Engineering, Cipla and Pidilite Industries: ROE of 11.3% to 22.6% and FY22 to FY26 revenue CAGR of 7.1% to 10.5%. Prices as of 13 Nov 2026.
Updated: 16 Nov 2026 • 2:29 pm
Posted by:

Quick Answer
The three mining casting, pharma and adhesive stocks to watch are AIA Engineering, Cipla and Pidilite Industries. Their return on equity ranges from 11.3% to 22.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 10.5%. Pidilite Industries leads on both return on equity at 22.6% and revenue growth at 10.5% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.
Mining casting, pharma and adhesive stocks let investors follow companies that serve a growing part of the Indian economy. AIA Engineering, Cipla and Pidilite Industries cover a mining castings maker, a pharmaceuticals company and an adhesives and construction chemicals maker.
This list covers three mining casting, pharma and adhesive stocks with complete current figures: AIA Engineering, Cipla and Pidilite Industries. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Mining Casting, Pharma and Adhesive Stocks?
Mining casting, pharma and adhesive stocks are listed companies that make high chromium grinding media and castings for mining and cement plants, make and sell medicines for India and global markets, and make adhesives, sealants and construction chemicals. Their earnings depend on mining activity, medicine demand and housing activity.
Mining Casting, Pharma and Adhesive Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| AIA Engineering | 3,186 | 34,194 | 27.0 | 50.7 | 15.8 | 0.00 |
| Cipla | 1,391.8 | 107,528 | 32.0 | 36.0 | 11.3 | 0.02 |
| Pidilite Industries | 1,525.7 | 150,953 | 56.4 | 35.1 | 22.6 | 0.04 |
On valuation, AIA Engineering and Cipla trade at a P/E below the industry P/E, while Pidilite Industries trades above it, which reflects the growth the market already expects. Readers comparing mining casting, pharma and adhesive stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Mining Casting, Pharma and Adhesive Stocks Have a Strong Roadmap in India?
Mining casting, pharma and adhesive stocks have a strong roadmap in India because steady mining and cement activity, wider access to quality medicines and strong demand for building chemicals keep widening the market for these companies.
- Mining castings. Mines and cement plants need durable parts.
- Pharmaceuticals. Patients need quality medicines.
- Adhesives. Homes and factories need bonding products.
Why AIA Engineering Features Among These Mining Casting, Pharma and Adhesive Stocks
Among the mining casting, pharma and adhesive stocks on this list, AIA Engineering makes high chromium wear-resistant castings used in grinding mills at cement, mining and power plants worldwide, and it sells a large share of its output to export customers.
In the June 2026 quarter, revenue grew 11.4% year on year to Rs 1,279 crore. Revenue rose from Rs 3,723 crore in FY22 to Rs 4,894 crore in FY26, a compound annual growth rate of 7.1%.
Net profit grew from Rs 620 crore in FY22 to Rs 1,269 crore in FY26, which works out to a compound annual growth rate of 19.6%. The company has a return on equity of 15.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 34,194 crore. The stock trades at a P/E of 27.0, below the industry P/E of 50.7.
Roadmap: The company benefits from global mining and cement activity and from the longer life its castings offer customers. A strong position in this niche supports repeat orders.
What to watch: Follow mining and cement demand, volume growth and raw material costs.
Why Cipla Features Among These Mining Casting, Pharma and Adhesive Stocks
Among the grinding ball, medicine maker and glue shares on this list, Cipla is a Mumbai-based pharmaceutical company with strengths in respiratory medicines, anti-infectives and chronic therapies. It sells branded and generic products in India, South Africa, the United States and other markets.
The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 107,528 crore. The stock trades at a P/E of 32.0, below the industry P/E of 36.0.
Revenue rose from Rs 22,044 crore in FY22 to Rs 29,045 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 2,559 crore in FY22 to Rs 3,870 crore in FY26, which works out to a compound annual growth rate of 10.9%. In the June 2026 quarter, revenue grew 1.6% year on year to Rs 7,330 crore.
Roadmap: The company is deepening its position in respiratory and complex generic products while expanding its consumer health and domestic prescription brands. A wide global footprint spreads its earnings across several markets.
What to watch: Follow new product launches in the United States and the growth of key domestic brands.
Why Pidilite Industries Features Among These Mining Casting, Pharma and Adhesive Stocks
Among the three companies on this list, Pidilite Industries is India's leading adhesives and construction chemicals company and the maker of Fevicol, Dr. Fixit, M-Seal and Fevikwik, among other brands.
Revenue rose from Rs 9,957 crore in FY22 to Rs 14,867 crore in FY26, a compound annual growth rate of 10.5%. Net profit grew from Rs 1,207 crore in FY22 to Rs 2,471 crore in FY26, which works out to a compound annual growth rate of 19.6%.
In the June 2026 quarter, revenue grew 21.0% year on year to Rs 4,644 crore, while net profit rose 30.3% to Rs 884 crore. The company has a return on equity of 22.6%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 150,953 crore. The stock trades at a P/E of 56.4, above the industry P/E of 35.1.
Roadmap: The company has a strong brand and a vast distribution network, and it continues to add products in waterproofing, paints and construction chemicals. Premium categories and new launches contribute to growth in housing and renovation.
What to watch: Check volume growth in consumer and bazaar products and the trend in raw material prices.
AIA Engineering vs Cipla vs Pidilite Industries on Key Financials
The table below sets the three mining casting, pharma and adhesive stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| AIA Engineering | 3,723 | 4,894 | 7.1% | 1,269 | 25.9% |
| Cipla | 22,044 | 29,045 | 7.1% | 3,870 | 13.3% |
| Pidilite Industries | 9,957 | 14,867 | 10.5% | 2,471 | 16.6% |
Pidilite Industries posts the highest return on equity in this group at 22.6%. Cipla has the largest FY26 revenue at Rs 29,045 crore, and Pidilite Industries shows the fastest revenue growth with a 10.5% compound annual rate. A useful habit with mining casting, pharma and adhesive stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| AIA Engineering | 1,147 | 1,279 | 11.4% |
| Cipla | 7,216 | 7,330 | 1.6% |
| Pidilite Industries | 3,839 | 4,644 | 21.0% |
Key Risks to Check Before Investing in Mining Casting, Pharma and Adhesive Stocks
Every theme carries risks that deserve a check before any decision. For these mining casting, pharma and adhesive stocks, the main points are: Long-term grinding ball, medicine maker and glue shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Capital spending cycles. Customer investment in plants and equipment can vary.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
- Housing cycles. Real estate and building demand can vary with rates and sentiment.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter mining casting, pharma and adhesive stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Mining Casting, Pharma and Adhesive Stocks
Mining casting, pharma and adhesive stocks reward investors who follow demand trends, order books and margins together. AIA Engineering, Cipla and Pidilite Industries each have a clear plan to grow. Based on the 13 November 2026 close, AIA Engineering trades at Rs 3,186, Cipla at Rs 1,391.8 and Pidilite Industries at Rs 1,525.7. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these mining casting, pharma and adhesive stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track mining casting, pharma and adhesive stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are mining casting, pharma and adhesive stocks?
Ans. Mining casting, pharma and adhesive stocks are listed companies that make high chromium grinding media and castings for mining and cement plants, make and sell medicines for India and global markets, and make adhesives, sealants and construction chemicals. Their earnings depend on mining activity, medicine demand and housing activity. This list looks at three of them, AIA Engineering, Cipla and Pidilite Industries, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.
Which mining casting, pharma and adhesive stocks are covered in this list?
Ans. This list covers AIA Engineering, Cipla and Pidilite Industries. Based on the 13 November 2026 close, AIA Engineering traded at Rs 3,186, Cipla at Rs 1,391.8 and Pidilite Industries at Rs 1,525.7. Their return on equity ranges from 11.3% to 22.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 10.5%.
Why do mining casting, pharma and adhesive stocks have a strong future roadmap in India?
Ans. Mining casting, pharma and adhesive stocks have a strong roadmap in India because steady mining and cement activity, wider access to quality medicines and strong demand for building chemicals keep widening the market for these companies. The main drivers are as follows. Mining castings. Mines and cement plants need durable parts. Pharmaceuticals. Patients need quality medicines. Adhesives. Homes and factories need bonding products. Together these factors give the companies on this list a visible path for growth over the coming years.
How has AIA Engineering performed financially?
Ans. Revenue rose from Rs 3,723 crore in FY22 to Rs 4,894 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 620 crore in FY22 to Rs 1,269 crore in FY26, which works out to a compound annual growth rate of 19.6%. In the June 2026 quarter, revenue grew 11.4% year on year to Rs 1,279 crore. The company has a return on equity of 15.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 34,194 crore. The stock trades at a P/E of 27.0, below the industry P/E of 50.7. Looking ahead, the company benefits from global mining and cement activity and from the longer life its castings offer customers. A strong position in this niche supports repeat orders.
How has Cipla performed financially?
Ans. Revenue rose from Rs 22,044 crore in FY22 to Rs 29,045 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 2,559 crore in FY22 to Rs 3,870 crore in FY26, which works out to a compound annual growth rate of 10.9%. In the June 2026 quarter, revenue grew 1.6% year on year to Rs 7,330 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 107,528 crore. The stock trades at a P/E of 32.0, below the industry P/E of 36.0. Looking ahead, the company is deepening its position in respiratory and complex generic products while expanding its consumer health and domestic prescription brands. A wide global footprint spreads its earnings across several markets.
How has Pidilite Industries performed financially?
Ans. Revenue rose from Rs 9,957 crore in FY22 to Rs 14,867 crore in FY26, a compound annual growth rate of 10.5%. Net profit grew from Rs 1,207 crore in FY22 to Rs 2,471 crore in FY26, which works out to a compound annual growth rate of 19.6%. In the June 2026 quarter, revenue grew 21.0% year on year to Rs 4,644 crore, while net profit rose 30.3% to Rs 884 crore. The company has a return on equity of 22.6%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 150,953 crore. The stock trades at a P/E of 56.4, above the industry P/E of 35.1. Looking ahead, the company has a strong brand and a vast distribution network, and it continues to add products in waterproofing, paints and construction chemicals. Premium categories and new launches contribute to growth in housing and renovation.
What risks should investors check before buying mining casting, pharma and adhesive stocks?
Ans. Investors should check a few risks before buying mining casting, pharma and adhesive stocks. Capital spending cycles. Customer investment in plants and equipment can vary. Regulatory approvals. Plant inspections and approvals can affect supplies. Housing cycles. Real estate and building demand can vary with rates and sentiment. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of mining casting, pharma and adhesive stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

Under Rs 1962 Stocks to Buy in November 2026: 5 Names on the Watchlist
16 November 2026

Under Rs 1770 Stocks to Buy in November 2026: 5 Names on the Watchlist
16 November 2026

Under Rs 1443 Stocks to Buy in November 2026: 5 Names on the Watchlist
16 November 2026

Under Rs 1267 Stocks to Buy in November 2026: 5 Names on the Watchlist
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Under Rs 1962 Stocks to Buy in November 2026: 5 Names on the Watchlist
Under Rs 1770 Stocks to Buy in November 2026: 5 Names on the Watchlist
Under Rs 1443 Stocks to Buy in November 2026: 5 Names on the Watchlist
Under Rs 1267 Stocks to Buy in November 2026: 5 Names on the Watchlist
Under Rs 1145 Stocks to Buy in November 2026: 5 Names on the Watchlist

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





